Achyut Healthcare Ltd (ACHYUT) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Achyut Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Statement of Deviation
Others (Uncategorized) · 26 Oct 2026, 11:35 pm
Achyut Healthcare Reports Nil Deviation in Utilization of Funds Achyut Healthcare Limited submitted its statement of deviation or variation under Regulation 32 of SEBI LODR Regulations for the quarter and half-year ended 30th Sep'26, confirming nil deviation across all historical fund-raising tranches. Total funds raised via public and preferential issues comprise ₹360.00 lakhs, ₹520.80 lakhs, ₹1,572.48 lakhs, and ₹348.00 lakhs across four allotments. Proceeds were deployed fully as allocated toward machinery, ongoing project capex (including laboratory equipment, AHU, civil works, and furnishings), issue expenses, and general corporate purposes without any variations.
Unaudited Result September, 2026
Financial Result · 26 Oct 2026, 11:26 pm
Achyut Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 166 (-34.8% YoY | -46.9% QoQ) ■ EBITDA: 3.4 (-74.5% YoY | -81.3% QoQ) ■ EBITDA Margin (%): 2.0 (-319 bps YoY | -375 bps QoQ) ■ PAT: 5.0 (-63.5% YoY | -65.4% QoQ) ■ EPS (INR): 0.00 (-64.9% YoY | -66.1% QoQ)
Outcome of Board Meeting
Outcome · 26 Oct 2026, 11:22 pm
Achyut Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 166 (-34.8% YoY | -46.9% QoQ) ■ EBITDA: 3.4 (-74.5% YoY | -81.3% QoQ) ■ EBITDA Margin (%): 2.0 (-319 bps YoY | -375 bps QoQ) ■ PAT: 5.0 (-63.5% YoY | -65.4% QoQ) ■ EPS (INR): 0.00 (-64.9% YoY | -66.1% QoQ)
Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 26 Oct 2026, 5:30 am
Achyut Healthcare Schedules Board Meeting on 26th Oct'26 for Q2 Earnings Approval Achyut Healthcare Limited announced that its Board of Directors will meet on 26th Oct'26 to consider and approve the company's unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in the company’s securities remains closed and will reopen 48 hours after the declaration of the financial results.
Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Rutvik S. Thakkar (DIN: 09387486) as a Independent ....
Change in Management · 01 Oct 2026, 12:22 am
Achyut Healthcare Reappoints Rutvik S. Thakkar as Independent Director for Five Years Achyut Healthcare Limited announced that its shareholders approved the reappointment of Mr. Rutvik S. Thakkar (DIN: 09387486) as an Independent Director for a second consecutive term of five years via a special resolution passed at its 31st AGM held on 30th Sep'26. A Chartered Accountant with over 11 years of experience across accounting, audit, and finance, Thakkar holds no equity shares in the company and is entitled to sitting fees of Rs. 36,000. He is not debarred from holding office by SEBI.
Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mrs. Sonu Lalitkumar Jain (DIN : 09387661) as a Independent ....
Change in Management · 01 Oct 2026, 12:18 am
Achyut Healthcare Re-Appoints Sonu Lalitkumar Jain as Independent Director Achyut Healthcare Limited announced that shareholders approved the re-appointment of Mrs. Sonu Lalitkumar Jain (DIN: 09387661) as an Independent Director for a second consecutive term of five years via a special resolution passed at its 31st AGM on 30th Sep'26. Jain holds over eight years of experience across securities markets, legal, and secretarial practices. Her proposed sitting fees stand at Rs. 36,000, and she holds no equity shares in the company. She is not debarred from holding directorial office by SEBI or any regulatory authority.
Intimation pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 regarding re-appointment Mr. Jigen J. Modi (DIN : 03355555) as a Managing ....
Change in Management · 01 Oct 2026, 12:16 am
Achyut Healthcare Reappoints Jigen J. Modi as Managing Director for Five Years Achyut Healthcare announced the reappointment of Mr. Jigen J. Modi as Managing Director for a five-year term via a special resolution passed at its 31st AGM on 30th Sep'26. Mr. Modi brings over 25 years of pharmaceutical business and marketing experience. Proposed annual remuneration stands at ₹1,80,000 p.a., unchanged from the remuneration drawn in FY25-26. He is related to Executive Director Amisha J. Modi and confirmed not debarred by SEBI or any regulatory authority.
Voting Result at the 31st Annual General Meeting of the Company and Scrutinizer''s Report-Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirments) Regulation, 2015
Annual General Meeting · 01 Oct 2026, 12:08 am
Outcome of AGM
Annual General Meeting · 29 Sept 2026, 6:25 pm
proceeding of 31st Annual General meeting held on 29th September, 2026.
Annual General Meeting · 29 Sept 2026, 6:20 pm
Submission of Annual Report under Regulation 34 of the SEBI (LODR) Regulations.
Others (Uncategorized) · 05 Sept 2026, 9:21 pm
Submission of Annual Report under Regulation 34 of the SEBI (LODR) Regulations.
Others (Uncategorized) · 05 Sept 2026, 8:58 pm
Cut-off Date for Notice of 31st Annual General Meeting (AGM) F.Y. 2025-26
Annual General Meeting · 05 Sept 2026, 8:50 pm
Appointment/Re-appointment of Managing Director and Independent Directors of the Company.
Change in Management · 05 Sept 2026, 8:41 pm
Achyut Healthcare Approves Director Re-Appointments and Schedules AGM Achyut Healthcare's board approved the re-appointment of Managing Director Jigen J. Modi for a five-year term starting 1st Nov'26, at a remuneration of up to Rs. 50,000 per month, subject to shareholder approval. The board also approved five-year re-appointments for Independent Directors Sonu Lalitkumar Jain and Rutvik Sanjaykumar Thakkar, effective 1st Nov'26, with sitting fees up to Rs. 50,000. Additionally, the company scheduled its Annual General Meeting for 29th Sep'26, fixing 22nd Sep'26 as the record date for voting eligibility.
Outcome of the Meeting of Board of Directors held on 05th September, 2026
Outcome · 05 Sept 2026, 8:38 pm
Achyut Healthcare Approves Director Re-Appointments and Schedules AGM Achyut Healthcare's Board has scheduled its AGM for 29th Sep'26, fixing 22nd Sep'26 as the voting record date. The Board approved the 5-year re-appointment of Managing Director Jigen J. Modi, effective 1st Nov'26 to 31st Oct'31, at a remuneration of up to Rs. 50,000 per month. Additionally, Independent Directors Sonu Lalitkumar Jain and Rutvik Sanjaykumar Thakkar were re-appointed for 5-year tenures starting 1st Nov'26, with sitting fees capped at Rs. 50,000 per month, subject to shareholder approval via special resolutions.
Notice of 31st Annual General Meeting of the Company for F.Y. 2025-26 to be held on 29th September, 2026.
Annual General Meeting · 05 Sept 2026, 8:32 pm
Outcome of Board Meeting of Board of Directors held on 05th September, 2026
Others (Uncategorized) · 05 Sept 2026, 8:16 pm
Achyut Healthcare Board Approves AGM Date and Director Re-Appointments Achyut Healthcare Limited's board approved the Notice of AGM and Director’s Report on 5th Sep'26. The 31st AGM is scheduled for 29th Sep'26 via VC/OAVM, with the record date set for 22nd Sep'26. The board approved the re-appointment of Mr. Jigen J. Modi as Managing Director for a five-year term from 1st Nov'26 to 31st Oct'31. Additionally, Mrs. Sonu Lalitkumar Jain and Mr. Rutvik Sanjaykumar Thakkar were approved for re-appointment as Non-Executive Independent Directors for five-year tenures, subject to shareholder approval.
Statement of Deviation/Variation for quarter ended June 30, 2026.
Others (Uncategorized) · 13 Aug 2026, 10:34 pm
Achyut Healthcare: No Deviation in Public Issue Fund Utilization for Jun'26 Quarter Achyut Healthcare confirmed no deviation or variation in the utilization of public issue proceeds for the quarter ended 30th Jun'26. The company reported on funds raised via public and preferential issues on multiple dates, including Rs. 360 lakhs (allotment 25 Mar'22) and Rs. 348 lakhs (allotment 23 Mar'26). All funds have been used as per stated objectives. From the Rs. 348 lakh issue, Rs. 260.23 lakhs have been utilized for ongoing projects, with the remainder kept in a bank account.
Submission of Financial Result for the quarter ended June 30, 2026
Financial Result · 13 Aug 2026, 10:25 pm
Achyut Healthcare Reports Q1FY27 Net Profit Up 46.6% YoY Achyut Healthcare reported a Q1FY27 net profit of ₹14.31 lakh, up 46.6% YoY but down 75.8% QoQ. Revenue from operations for the quarter ended 30 Jun'26 stood at ₹312.74 lakh, a marginal 1.1% YoY increase, while declining 28.7% QoQ. Total expenses were ₹298.86 lakh, a 2.6% YoY decrease and 33.1% QoQ fall. The company's EPS for the quarter was ₹0.0059, compared to ₹0.0041 in Q1FY26 and ₹0.0024 in Q4FY26. The results were approved by the board on 13 Aug'26.
Outcome of Board Meeting held on August 13, 2026
Outcome · 13 Aug 2026, 10:18 pm
Achyut Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 313 (+1.1% YoY | -28.7% QoQ) ■ EBITDA: 18.1 (+172.4% YoY | +566.9% QoQ) ■ EBITDA Margin (%): 5.8 (+365 bps YoY | +518 bps QoQ) ■ PAT: 14.3 (+46.6% YoY | +152.8% QoQ) ■ EPS (INR): 0.01 (+43.9% YoY | +145.8% QoQ)
Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 13 Aug 2026, 5:30 am
Achyut Healthcare Board Meeting Set for Aug 13, 2026 to Approve Q1 Results Achyut Healthcare (BSE: 543499) has scheduled a Board of Directors meeting for Thu, 13th Aug'26. The primary agenda is to consider and approve the unaudited financial results for the quarter ended 30th Jun'26. In accordance with SEBI regulations, the trading window for dealing in the company's securities will remain closed until 48 hours after the financial results are declared. The meeting will be held at the company's registered office in Ahmedabad.
Revised outcome of Board Meeting held on held on Tuesday, July 14, 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Revision of outcome · 15 Jul 2026, 5:10 pm
Achyut Healthcare to Amalgamate with Zenith Healthcare The Board of Achyut Healthcare Limited ("Transferor") on 14th Jul'26 approved a Scheme of Amalgamation with Zenith Healthcare Limited ("Transferee"). The transaction is a related-party deal conducted at arm's length. Per the share exchange ratio, Achyut shareholders will receive 119 shares of Zenith for every 50 shares held. Post-merger, Zenith's promoter holding will increase from 28.74% to 45.80%, while public shareholding will decrease from 71.26% to 54.20%. Achyut Healthcare will be dissolved upon completion, pending regulatory approvals.
After considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has inter-alia considered and approved a Scheme of Amalgamation of ....
Others (Uncategorized) · 15 Jul 2026, 3:06 am
Achyut Healthcare to Amalgamate with Zenith Healthcare The Board of Directors on 14th Jul'26 approved a Scheme of Amalgamation for Achyut Healthcare Limited (Transferor) to merge into Zenith Healthcare Limited (Transferee). The merger is a related-party transaction. As of 31st Mar'26, Achyut had a net worth of INR 3506.12 lakhs and Zenith had INR 742.42 lakhs. The share exchange ratio is set at 119 shares of Zenith for every 50 shares of Achyut. Post-amalgamation, promoter holding in Zenith will increase from 28.74% to 45.80%.
After considering the recommendation of the Audit Committee and the Committee of Independent Director of the Company, has inter-alia considered and approved a Scheme of Amalgamation of ....
Others · 15 Jul 2026, 2:58 am
Achyut Healthcare to Amalgamate with Zenith Healthcare in Share-Swap Deal Achyut Healthcare Limited's board approved a scheme of amalgamation with Zenith Healthcare Limited on 14th Jul'26. Achyut, the transferor, will merge into Zenith, the transferee. The deal is a share-swap with an exchange ratio of 119 Zenith shares for every 50 Achyut shares. Post-merger, Zenith's promoter stake will increase from 28.74% to 45.80%, while public shareholding will decrease from 71.26% to 54.20%. Achyut Healthcare will be dissolved. The amalgamation is subject to shareholder and regulatory approvals, including NCLT.
Outcome of the Board Meeting held on Tuesday, July 14, 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding ....
Others (Uncategorized) · 15 Jul 2026, 2:46 am
Achyut Healthcare Board Approves Amalgamation with Zenith Healthcare On 14th Jul'26, Achyut Healthcare’s board approved its amalgamation into Zenith Healthcare. For every 50 shares held in Achyut (Transferor), shareholders will receive 119 shares of Zenith (Transferee). Post-merger, the promoter holding in the combined entity (Zenith) will increase from 28.74% to 45.80%, while public shareholding will decrease from 71.26% to 54.20%. Achyut Healthcare will be dissolved. The scheme aims for operational synergies and an enhanced product portfolio, and is subject to shareholder and regulatory approvals.